FREQUENCY OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN DIABETIC INDIVIDUALS USING NON-INVASIVE SCORE.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in people with type 2 diabetes mellitus and may progress to clinically important liver disease. The Fatty Liver Index (FLI) is a simple non-invasive score derived from routinely available anthropometric and biochemical variables and...